Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
This peptide is not approved for human or veterinary use and has not been evaluated for safety or efficacy in humans
Iran War Spokane Wildfires World Politics Entertainment HealthWatch MoneyWatch Crime Space Sports Brand Studio The Free Press Local News Atlanta Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas Live CBS News 24/7 Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas 48 Hours 60 Minutes Shows 48 Hours 60 Minutes CBS Evening News CBS Mornings CBS Morning News CBS Reports CBS Saturday Morning The Daily Report The Dish Face the Nation Sunday Morning The Takeout Things That Matter The Uplift CBS News Investigates CBS News Confirmed Podcasts Newsletters Download Our App CBS News Team Executive Team Brand Studio Paramount+ Join Our Talent Community RSS Feeds Texas | News Weather Sports Video Texas Monthly Local Business Eye on Politics Politics Consumer Education Tech The I-Team HealthWatch Entertainment Texas Weather Live Radar Closings/Cancellations Weather Watcher Network Gardening 101 Weather on Wheels Mobile 11 Climate Connection All Sports CBS Sports HQ Cowboys Rangers Mavericks Stars FC Dallas Wings NASCAR Golf Tennis College Sports High School Sports Station Info CBS 11 / TXA 21 Advertise CBS Television Jobs Upload Your Photos Galleries Download the App Memorials Watch CBS News Health researchers say GLP-1 drug may lower health risks Health researchers with the Cleveland Clinic say the GLP-1 drug, Tirzepatide, may lower health risks such as heart and kidney failure
Cholesterol should be considered along with other factors known to make a heart attack or stroke more likely
A recent randomized placebo-controlled trial published by Scirica et al, known as SAVOR-TIMI 53, found no significant difference in ischemic events but did observe higher hospitalizations for heart failure with saxagliptin
